
Growth equity vs. venture capital largely comes down to when the money goes in and what it is betting on. Venture capital typically funds companies before the business model is proven and expects many investments to fail while a few return the fund. Growth equity typically funds companies whose model already works, expects fewer losses, and stacks up moderate multiples instead of one enormous one.
Stage drives the loss rate. In our view, the loss rate then shapes most of the rest: deal terms, how deep diligence goes, how many companies a fund owns, the daily work, and what each career pays.
Growth equity vs. venture capital: the core difference
A venture investor underwrites a possibility. A growth investor underwrites a trajectory.
Cambridge Associates characterizes a "classic" growth equity company as founder-owned with no prior institutional capital, no or limited leverage, a proven business model with an established product and existing customers, substantial organic revenue growth (usually above 10 percent and often above 20 percent), and EBITDA positive or expected to be within 12 to 18 months.
A seed or Series A company usually has few of those attributes. The round often exists to find out whether it ever will.
Difference 1: stage and company profile
- Venture capital invests from pre-seed through Series B or C. Revenue may be zero at entry. The investor is betting on the team, the market, and the product's ability to find fit.
- Growth equity invests once the model works. Carta's guide describes the targets as companies with a proven business model and demonstrated product-market fit, a history of strong and consistent revenue growth, profitability or a clear path to it, and a strong, often founder-led management team that stays in place after the investment. PitchBook is blunter: growth recipients are "usually too small for a buyout or not growing fast enough for a VC firm."
Neither source publishes a revenue threshold, and in practice the entry point varies widely by sector and by fund size. We find Cambridge's growth-rate and EBITDA test a more useful filter than any revenue number.
Difference 2: risk and loss rates in growth equity vs. venture capital
This may be the clearest number separating the two. In Cambridge Associates' growth equity research, the capital loss ratio was 13.7 percent for growth equity as of June 30, 2018, against 32.7 percent for venture capital and 10 to 15 percent for buyouts over the same measurement.
Venture lost roughly a third of its capital. Growth lost about a seventh.
Cambridge also found that as of December 31, 2017, roughly two thirds of realized growth equity companies growing revenue faster than 20 percent a year exited at a gross multiple on invested capital of 2.0x or better, and that just over 40 percent of all the investments it analyzed fell into that 20-percent-plus growth category.
The portfolios are built for those numbers. A venture fund is generally designed to survive losing roughly a third of its capital, because one or two positions can return the whole fund. A growth fund usually can't count on a 50x outcome, so it focuses on avoiding losses and compounding many good-but-not-spectacular exits. The venture capital fund performance metrics guide covers how those outcomes turn into TVPI, DPI and IRR.
Difference 3: returns
Cambridge Associates' US PE/VC benchmark commentary for calendar year 2025 shows the trade in one line: the US venture capital index returned 21.1 percent for the year, the growth equity component of the US private equity index returned 11.9 percent, and buyouts returned 7.6 percent. Cambridge credits technology exposure for the venture result.
Two caveats. Venture returns swing far more from year to year than growth returns do. And both index numbers are largely unrealized marks rather than cash, the line that separates any private fund from a daily-priced book, as hedge fund vs. venture capital works through.
Over longer stretches the ranking flips back. The same Cambridge growth equity paper found that growth equity's fund-level returns beat venture capital over every time period of 15 years or fewer measured in that research, and were comparable to buyouts. Venture pulled ahead only over 20-plus-year horizons, thanks to outsized performance in the mid and late 1990s.
Our read: venture has the higher ceiling and a wider spread between good and bad managers. Growth has the tighter distribution. Which one looks better depends heavily on the window you pick.
Difference 4: deal terms and structure
Both strategies buy preferred stock, but the term sheets diverge:
| Term | Venture (seed to Series B) | Growth equity |
|---|---|---|
| Instrument | SAFE, note, or preferred | Preferred, sometimes with a secondary component |
| Liquidation preference | 1x non-participating is typical | 1x is typical; structured terms appear in tougher markets |
| Governance | Board seat for the lead, light protective provisions | Board seat, independent director rights, heavier protective provisions |
| Redemption rights | Rare | More common |
| Valuation basis | Team, market, comparables, story | Revenue multiples, growth-adjusted multiples, public comps |
The early-stage side is pretty settled. Cooley's Q2 2026 venture financing report found 95.8 percent of the deals it tracked carried a 1x liquidation preference and 96.4 percent were non-participating, with redemption provisions in 5.4 percent, down from 6.4 percent in the prior quarter.
Growth rounds negotiate more of this from scratch. A growth investor also often buys shares from founders or early backers, which is one reason a growth round can be a liquidity moment for seed investors.
Difference 5: diligence and daily work
Venture diligence is about people and markets: reference calls, customer conversations, competitive mapping, and a judgment about whether this founder can build a company. At seed, a cap table and a simple dilution model are often the main spreadsheets that matter.
Growth diligence looks like private equity: cohort analysis, revenue quality, gross margin by product, sales efficiency, net revenue retention, working capital, a full three-statement model, and a returns model with sensitivity tables. Quality of earnings reviews by an accounting firm are common. The financial due diligence guide walks through the workflow.
The day-to-day follows. A venture associate usually spends more time sourcing and meeting founders. A growth associate usually spends more time in Excel and on outbound calls to companies that aren't raising yet.
Difference 6: portfolio construction and check size
A venture fund holds many positions and reserves a large share of the fund for follow-ons, accepting that many positions won't return capital. A growth fund holds fewer, larger positions and reserves less, because the companies are closer to exit and less likely to need rescue capital. Neither count is magic; as we argue in our take on portfolio size, the mistake is picking the number by accident.
Check sizes follow the stage. Seed rounds are measured in single-digit millions and growth rounds routinely in tens or hundreds of millions, with the exact band varying by fund size rather than following any published standard. The market backdrop reinforces the split: the Q2 2026 PitchBook-NVCA Venture Monitor reports that deals of $100M or more captured 87.5 percent of the $412.7 billion deployed in the first half of 2026. This year, most of the money is moving at the later stages.
Difference 7: careers and pay in growth equity vs. venture capital
Who gets hired. Growth equity firms often favor candidates with investment banking, private equity or transaction-heavy consulting backgrounds, because the modeling test is real. Venture firms hire more broadly: operators, founders, product managers, engineers and sector specialists, as well as bankers. The venture capital career path guide maps the ladder.
What it pays. Venture5's 2025 Venture Capital Salary Survey of more than 700 US venture professionals publishes base salary only, with medians of about $80K for analysts, $130K for associates, $150K for senior associates, $200K for VPs and principals and $300K for investment partners. It reports no bonus figures and no carry figures by role.
Mergers & Inquisitions estimates that carry is absent at analyst level, extremely unlikely for a pre-MBA associate, small at senior associate, and real from principal upward, though still well below what partners earn. Growth equity roles at large firms generally track private equity pay scales, which sit above venture at junior levels. Public data on growth-specific pay is thin, though, and ranges move with fund size.
What the work rewards. Venture tends to reward judgment about people and markets, sourcing ability and patience. Growth tends to reward analytical rigor, negotiation, and running a process against competing bidders.
"But growth equity is just late-stage venture"
At the edges, the two do blur. Plenty of venture firms write growth checks, and plenty of growth funds invest in companies that still burn cash.
But.
The seat and the job are different even when the logo is the same. A growth investor's worst day is overpaying for a good company. A venture investor's worst day is missing the one company that mattered. Those fears produce different habits, different models and different careers.
Where we land on which path fits you
Three questions worth answering honestly:
- Do you want to be paid for finding or for analyzing? Meeting 20 founders a week and forming a view before the data exists leans venture. Being right because the numbers are right leans growth.
- How do you feel about being wrong most of the time? Venture investors are often wrong on most deals by design. Growth investors are generally expected to be right on most.
- Where do you want to be in ten years? Venture partners tend to be judged on a handful of outliers over a decade, growth partners on consistency and process.
Neither seat is the better one. It depends on which kind of wrong you can live with.
Those questions get easier once you've had to judge a company with almost no data. 1752vc's Venture Fellow program gives eight weeks of that in live virtual sessions, with Fellows working from the real pitch materials early companies send, which at seed is close to the whole evidence base. It is aimed at aspiring VCs and professionals moving into investing, and applications are reviewed on a rolling basis, so the early-stage side can be tested without leaving a growth seat first.
For the neighboring comparisons, see private equity vs. venture capital and the standalone growth equity explainer.
The bottom line
Growth and venture both buy preferred stock in private companies. That's about where the similarity ends. One is built to avoid losses; the other is built to survive them.
Growth equity needs most deals to work.
Venture needs one deal to work spectacularly.
Key takeaways
- Growth equity vs. venture capital is largely a difference of stage: venture usually funds unproven models, growth funds proven ones, and Cambridge Associates' classic growth profile is a founder-owned business growing organically above 10 percent with EBITDA positive or close.
- Cambridge put the capital loss ratio at 13.7 percent for growth equity as of June 30, 2018, against 32.7 percent for venture capital and 10 to 15 percent for buyouts.
- Cambridge also found roughly two thirds of realized growth companies growing above 20 percent exited at 2.0x gross MOIC or better as of December 31, 2017.
- In calendar 2025 the US venture index returned 21.1 percent against growth equity's 11.9 percent, but growth beat venture over every window of 15 years or fewer in Cambridge's research.
- Growth deals carry heavier governance, more frequent redemption rights, metric-based valuation and often a secondary component; growth recruiting often looks like private equity recruiting and tends to pay above venture at junior levels.
Frequently asked questions
Venture capital invests in early companies before the business model is proven, expecting many failures offset by a few outsized wins. Growth equity takes minority stakes in companies with a proven model, real revenue and profits in sight, expecting few losses and many moderate wins. Cambridge Associates measured the gap: a 13.7 percent capital loss ratio for growth equity as of June 30, 2018, against 32.7 percent for venture.
Generally not. Growth equity tends to be lower risk per deal. Cambridge Associates found growth equity lost 13.7 percent of invested capital as of June 30, 2018, compared with 32.7 percent for venture capital and 10 to 15 percent for buyouts. The trade-off is a lower ceiling, because growth deals rarely return 50x.
At junior levels, often yes at large growth firms, because their pay scales track private equity rather than venture. Venture5's 2025 survey put median venture base salary at about $130K for associates and $300K for investment partners, and publishes no bonus amounts or carry figures by role. Growth roles at large firms typically sit above those base numbers, though ranges depend heavily on fund size.
It depends on what you enjoy. Growth equity often suits people who like financial analysis, process and negotiation, and it recruits from banking, private equity and consulting. Venture often suits people who like sourcing, forming views on unproven markets and working closely with founders, and it hires from a much wider range of backgrounds.
Yes, and it tends to be easier earlier in a career. Growth firms usually want modeling and transaction skills, so venture associates who have run full diligence processes and built returns models are credible candidates. Moving the other way is also common, especially for people who want to work with earlier-stage companies and decide faster.
Sources
- Cambridge Associates: Growth Equity, Turns Out It's All About the Growth
- Cambridge Associates: US PE/VC Benchmark Commentary, Calendar Year 2025
- PitchBook: Characteristics of Growth Deals
- PitchBook: Q2 2026 PitchBook-NVCA Venture Monitor
- Carta: Growth Equity Overview, Uses, and Lifecycle
- Cooley: Q2 2026 Venture Financing Report
- Venture5: 2025 Venture Capital Salary Survey
- Mergers & Inquisitions: Venture Capital Careers
Disclaimer: This guide is for general education only and is not legal, tax or investment advice. Laws, market data and program terms change, so it may not reflect the latest developments or fit your situation. Treat it as a starting point, not a source of truth, and talk to a qualified lawyer, accountant or financial adviser before you make decisions.


